Pending FDA User-Fee Legislation May Be ‘Big Shot’ For Cosmetics Reg Reform
This article was originally published in The Rose Sheet
The Personal Care Products Council expects at least three cosmetics reform bills to make reappearances in the 115th Congress, but the best opportunity for updating regulations may involve tacking related provisions onto must-pass FDA user-fee bills this year. Top execs discussed the current legislative landscape during the “Washington Report” session of the trade group’s annual meeting in Palm Beach, Fla.
You may also be interested in...
Cosmetics Reg Reform Ill-Situated As Trump, FDA Explore 'Burden Reduction'
Any movement to advance proposed cosmetics reform legislation could be seen as running counter to President Trump's executive orders earlier this year, which now have FDA centers seeking "broad public comment" on how to achieve "meaningful burden reduction."
ICMAD Broadens Advocacy Focus With Cosmetics Reform A Low Priority In Congress
Legislation to update cosmetics regulations may not have legs in the 115th Congress, but the Independent Cosmetic Manufacturers and Distributors will have an active presence on Capitol Hill regardless. President and CEO Pam Busiek says the small-business trade group will continue working to educate lawmakers on regulatory reform issues while expanding its advocacy work to address tax and trade concerns.
Cosmetics Provisions Unlikely To Catch Ride On FDA User-Fee Bill
With the release of an atypically lean, clean FDA user-fee reauthorization draft bill, it’s doubtful that cosmetics regulatory reform language will get tacked onto the must-pass legislation. Stakeholders likely will refocus their efforts on standalone cosmetics legislation to modernize FDA’s oversight of the industry.